Sat, 02-Jul-2022


Bayer Takes on Astellas in Purchase of Experimental ...

Bayer moved to acquire a prospective non-hormonal menopause relief for an initial $425 million to strengthen its women’s healthcare business, in a challenge to a similar development venture at Astellas. ... August 13, 2020 9:40 am By Neha Mule

Related News